In the past few years, a large majority (>70%) of the launches in face care market claimed moisturizing benefits.But consumers also want benefits to last. ‘Long-lasting hydration’ is sought by 73% of French women and ‘long lasting’ is the first benefit consumers want in a body care product.
87% of consumers are interested in Hyaluronic Acid for face care. This makes HA the ideal candidate to claim about skin moisturization. However, HA has also its limitations. It is the best what can be offered when it comes to hydration in leave-on products, but it simply doesn’t work in rinse-off formulations.
Givaudan managed to develop a new grafted HA, based on cationisation, switching its negative charge to a positive one. This resulted in Primalhyal Hydra[+], a novel generation of HA, with low molecular weight and high cationization degree. Thanks to this, Primalhyal Hydra[+] strongly binds to the skin, to deliver barrier function improvement and intense moisturization in rinse-off formulations. In leave-on applications it outperforms the benefits of ‘standard’ grades of HA.
Primalhyal Hydra[+] offers following benefits:
INCI: Hydroxypropyltrimonium Hyaluronate
Dosage: 0.03-0.1%
For more information, or to request a sample, please contact our technical manager Gerben Potters (technical.manager@gova-benelux.com)
GOVA INGREDIENTS
Jac Jansensweg 7
4631 SL Hoogerheide,
The Netherlands